ß-Escin and chokeberry extract diet supplementation in healthy smokers as potential anti- inflammatory and antioxidant protection – a pilot study

Authors:

Abstract
Introduction: β-Escin is a mixture of triterpenoid saponins extracted from the fruit of horse chestnut tree (Aesculus hippocastanum. L). Recent advances in the understanding of β-escin potent anti-inflammatory effects provides rationale for its novel uses beyond the current vascular indications. The active compounds found in chokeberry (Aronia melanocarpa) also exhibit antioxidant activity. The aim of the study was to evaluate the antioxidant and anti-inflammatory effects of β-escin and chokeberry extract used as functional food in healthy tobacco smokers. Methods: We recruited 9 smoking participants who received 10 mg of water soluble β-escin and 5 mg of chokeberry juice concentrate for 2 weeks. Control group included 5 healthy nonsmokers with no escin and chokeberry supplementation. The spirometry and sputum induction were performed in study patients at baseline (V0), after 1 (V1) and 2 weeks (V2) of escin and chokeberry supplementation. In controls, the same procedures were conducted at V0 and V1 time points. The antioxidant capacity, acetaldehyde, IL-6 and IL-8 level were measured in sputum. Results: An elevated baseline IL-6 level (p=0.03) but not IL-8 (p=0.81) or acetaldehyde (p=0.07) levels were found in smokers compared to non-smokers. The decrease in the number of sputum neutrophils was observed after one week of β-escin and chokeberry supplementation (p=0.04). Conclusion: This preliminary study suggested that low dose β-escin and chokeberry supplementation may be associated with significant reduction of airway neutrophil number but no other evaluated biomarkers, further studies are needed.